Determination of healing response by immunostimulant therapy (levamisole) in cutaneous leishmaniasis.
D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007896:Leishmaniasis / Q000188:drug therapy* / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use*; D008875:Middle Aged; D012293:Rifampin / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology
D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008795:Metronidazole; D007978:Levamisole; D012293:Rifampin